Stocks
Funds
Screener
Sectors
Watchlists

Latest DCF Advisers, LLC Stock Portfolio

DCF Advisers, LLC Performance:
2024 Q3: -0.38%YTD: 10.32%2023: 12.36%

Performance for 2024 Q3 is -0.38%, and YTD is 10.32%, and 2023 is 12.36%.

About DCF Advisers, LLC and 13F Hedge Fund Stock Holdings

In it's latest 13F Holdings report, DCF Advisers, LLC reported an equity portfolio of $250.2 Millions as of 30 Sep, 2024.

The top stock holdings of DCF Advisers, LLC are MU, GOOG, . The fund has invested 7.3% of it's portfolio in MICRON TECHNOLOGY INC and 4.7% of portfolio in ALPHABET INC.

The fund managers got completely rid off SNOWFLAKE INC (SNOW), JOHNSON & JOHNSON (JNJ) and SAMSARA INC (IOT) stocks. They significantly reduced their stock positions in REVANCE THERAPEUTICS INC (RVNC), AT&T INC (T) and OVID THERAPEUTICS INC (OVID). DCF Advisers, LLC opened new stock positions in NEWAMSTERDAM PHARMA COMPANY (NAMS), ROYALTY PHARMA PLC (RPRX) and METHANEX CORP. The fund showed a lot of confidence in some stocks as they added substantially to ARQ INC (ADES), CITIGROUP INC (C) and SPROTT FDS TR.

DCF Advisers, LLC Annual Return Estimates Vs S&P 500

Our best estimate is that DCF Advisers, LLC made a return of -0.38% in the last quarter. In trailing 12 months, it's portfolio return was 19.16%.

New Buys

Ticker$ Bought
newamsterdam pharma company564,400
royalty pharma plc424,350
methanex corp310,050
nextnav inc127,330

New stocks bought by DCF Advisers, LLC

Additions

Ticker% Inc.
arq inc231
citigroup inc167
sprott fds tr161
amazon com inc102
evotec ag88.82
ionis pharmaceuticals inc71.74
zai lab ltd38.75
vaneck etf trust38.69

Additions to existing portfolio by DCF Advisers, LLC

Reductions

Ticker% Reduced
revance therapeutics inc-92.23
at&t inc-78.62
coherus biosciences inc-74.07
ovid therapeutics inc-64.67
apple inc-55.56
broadcom inc-48.72
zoom video communications in-41.67
biohaven ltd-40.04

DCF Advisers, LLC reduced stake in above stock

Sold off

Ticker$ Sold
revance therapeutics inc-386,952
nuveen floating rate income-255,175
samsara inc-337,000
snowflake inc-439,043
johnson & johnson-438,480
biogen inc-231,820

DCF Advisers, LLC got rid off the above stocks

Sector Distribution

DCF Advisers, LLC has about 29.7% of it's holdings in Others sector.

Sector%
Others29.7
Healthcare27.2
Technology21
Communication Services6.8
Consumer Cyclical5.5
Financial Services4.1
Energy2.6
Consumer Defensive1.6
Industrials1.5

Market Cap. Distribution

DCF Advisers, LLC has about 58% of it's portfolio invested in the large-cap and mega-cap stocks.

Category%
LARGE-CAP31.3
UNALLOCATED30
MEGA-CAP26.7
SMALL-CAP6
MID-CAP4.7
MICRO-CAP1.3

Stocks belong to which Index?

About 62.1% of the stocks held by DCF Advisers, LLC either belong to S&P 500 or RUSSELL 2000 index.

Index%
S&P 50052.5
Others37.9
RUSSELL 20009.6
Top 5 Winners (%)%
RVNC
revance therapeutics inc
102.0 %
VRDN
viridian therapeutics inc
64.2 %
OVID
ovid therapeutics inc
44.7 %
BNED
barnes & noble ed inc
37.3 %
KIRK
kirklands inc
34.4 %
Top 5 Winners ($)$
ORCL
oracle corp
1.0 M
ABBV
abbvie inc
0.8 M
TPB
turning pt brands inc
0.8 M
RVNC
revance therapeutics inc
0.7 M
GLD
spdr gold tr
0.6 M
Top 5 Losers (%)%
WOLF
wolfspeed inc
-57.4 %
AVGO
broadcom inc
-39.9 %
LRCX
lam research corp
-23.4 %
INTC
intel corp
-20.4 %
MU
micron technology inc
-19.6 %
Top 5 Losers ($)$
MU
micron technology inc
-4.5 M
GOOG
alphabet inc
-1.2 M
AVGO
broadcom inc
-0.6 M
PRTA
prothena corp plc
-0.4 M
IONS
ionis pharmaceuticals inc
-0.3 M

DCF Advisers, LLC Holdings Map

This heatmap illustrates the top 50 positions within the fund's portfolio.

Current Stock Holdings of DCF Advisers, LLC

DCF Advisers, LLC has 79 stocks in it's portfolio. About 34.9% of the portfolio is in top 10 stocks. MU proved to be the most loss making stock for the portfolio. ORCL was the most profitable stock for DCF Advisers, LLC last quarter.

Last Reported on: 13 Nov, 2024
TickerNamesorted ascending% PortfolioShares Held$ ValueType% ChangeOptions